AzTrials
AzTrials

Age-related Hearing Impairment 1HEARSNCT03442296

Baltimore HEARS: Hearing Health Equity Through Accessible Research & Solutions

A study testing Baltimore HEARS in people with Age-related Hearing Impairment 1 and Personal Communication, run by Johns Hopkins University at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Age-related hearing loss is highly prevalent and hearing health care is underutilized. The primary objective of the proposed randomized controlled trial is to investigate the efficacy of a community health worker (CHW)-delivered hearing loss intervention program. Read more about this study

Who is it for?
Ages 60 to 100 yearsHealthy volunteers can take part
What is being tested?
Baltimore HEARS
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
151 participants
Where
2 sitesUnited States
Study dates
18 Apr 2018to 14 Jul 2021
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 to 100 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age 60 years or older
  • English-speaking
  • Aural-oral verbal communication as primary communication modality
  • Post-lingual hearing loss (Audiometric pure tone averages [0.5-4kHz] in both ears >25 dB)
  • Does not currently use a hearing amplification device or hearing aid
  • Signed informed consent to participate in all study related activities
Show all 9Show fewer
  • Willing to regularly use listening device once provided for the remainder of their time in the study
  • Hearing handicap as measured by HHIE-S score >8
  • Able to follow study instructions

Who cannot join

  • Individuals who do not fulfill inclusion criteria
  • Evidence of ear disease or pathology requiring further medical evaluation

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Catholic Charities

    Baltimore, Maryland, 21201

  • Weinberg Senior Living Communities

    Baltimore, Maryland, 21215

Other trials in United States

About this study

Official title: Baltimore HEARS Study: Addressing Hearing Impairment and Social Engagement Through Community-delivered Hearing Care

Age-related hearing loss is highly prevalent and hearing health care is underutilized. The primary objective of the proposed randomized controlled trial is to investigate the efficacy of a community health worker (CHW)-delivered hearing loss intervention program. A preceding pilot study demonstrated preliminary effectiveness of the intervention program in reducing self-reported hearing handicap, and highlighted its acceptability among the target demographic. The proposed trial will now expand upon lessons learned through previous pilot studies and expand to other affordable residences for low-to-moderate income older adults in Baltimore. Primary outcome measurements will investigate intervention effects on hearing handicap, with secondary measurements investigating effects on domains such as social isolation and quality of life. This trial is a first-in-kind investigation of a novel community-based intervention that addresses hearing loss in a vulnerable, urban population.

Being tested
Baltimore HEARS
Medical subject headings
Age-Related Hearing Impairment 1, Communication

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Baltimore HEARSBehavioural

    Tailored aural rehabilitation for participant and communication partner (if applicable)

  • Baltimore HEARSDevice

    Tailored fitting and programming of a personal sound amplifier. This will be accompanied by a component of aural rehabilitation.

Study groups in NCT03442296
Study groupRoleWhat they receive
Immediate Treatment GroupExperimentalImmediate treatment with Baltimore HEARS intervention
Receives: Behavioral: Baltimore HEARS; Device: Baltimore HEARS
Delayed Treatment GroupPlacebo comparator3-month delayed treatment with Baltimore HEARS intervention
Receives: Behavioral: Baltimore HEARS; Device: Baltimore HEARS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change From Baseline in Hearing Handicap Inventory for the Elderly (HHIE-S)

    Measure was collected through a one-on-one interview with a trained data collector. Higher scores indicate increased hearing handicap.

    Scoring:

    0-8 suggests no hearing handicap 10-24 suggests mild-moderate hearing handicap 26-40 suggests significant hearing handicap

    Change from baseline is reported. An increase in the score from baseline (a positive number) indicates a worsening in hearing handicap.

    Measured: Baseline and 3 months post-intervention (Immediate Group) or 3 months post-baseline (Delayed Group)

Secondary outcomes (31)
  1. Change From Baseline in Revised UCLA Loneliness Scale

    Measure was collected via a one-on-one interview conducted by a trained data collector.

    Score is the sum of 20-item self-reported measure. Scores range from 20 to 80.

    Score ranges:

    20-34 - Low degree of loneliness 35-49 - Moderate degree of loneliness 50-64 - Moderately high degree of loneliness 65-80 - High degree of loneliness.

    Change from baseline is reported. An increase in the score from baseline (a positive number) indicates a worsening in degree of loneliness.

    Measured: Baseline and 3 months post-intervention (Immediate Group) or 3 months post-baseline (Delayed Group)

  2. Change From Baseline in Self-reported Depression in Patient Health Questionnaire (PHQ-9)

    Measure collected via one-on-one interview conducted by trained data collectors.

    Total of 9 questions, scored from 0 to 3. The score from each question are summed to a total score, which can range from 0 to 27.

    Interpretation of Total Score Total Score Depression Severity 0 No depression 1-4 Minimal depression 5-9 Mild depression 10-14 Moderate depression 15-19 Moderately severe depression 20-27 Severe depression.

    Change from baseline is reported. An increase in the score from baseline (a positive number) indicates a worsening in depression severity.

    Measured: Baseline and 3 months post-intervention (Immediate Group) or 3 months post-baseline (Delayed Group)

  3. Change From Baseline in Short Form-12 (SF-12) Mental Component Score

    The 12-Item Short Form Survey (SF-12) was collected through a one-on-one interview with a trained data collector.

    The 12-Item Short Form Survey (SF-12) measures the construct of self-reported health-related quality of life. Here we report the mental component which relates to mental health functioning. Score ranges from 0-100 with higher scores indicating better mental health functioning.

    Change from baseline is reported. An increase in the score from baseline (a positive number) indicates a better health state.

    Measured: Baseline and 3 months post-intervention (Immediate Group) or 3 months post-baseline (Delayed Group)

  4. Change From Baseline in Short Form -12 (SF-12) Physical Component Score

    The 12-Item Short Form Survey (SF-12) was collected through a one-on-one interview with a trained data collector.

    The 12-Item Short Form Survey (SF-12) measures the construct of self-reported health-related quality of life. Here we report the physical component which relates to physical health functioning. Score ranges from 0-100 with higher scores indicating better physical health functioning.

    Change from baseline is reported. An increase in the score from baseline (a positive number) indicates a better health state.

    Measured: Baseline and 3 months post-intervention (Immediate Group) or 3 months post-baseline (Delayed Group)

  5. Change From Baseline in Cohen Social Network Index (SNI): Network Diversity

    Change from baseline in total number of high contact roles the participant interacts with at least every 2 weeks (such as family, friends, work). Maximum of 12 roles included on the measure. An increase in the score from baseline (a positive number) indicates a more diverse network.

    Measured: Baseline and 3 months post-intervention (Immediate Group) or 3 months post-baseline (Delayed Group)

  6. Change From Baseline in Cohen Social Network Index (SNI): Social Network Size

    Change from baseline in total number of individuals in high contact roles the participant interacts with at least every 2 weeks (such as family, friends, work). .An increase in the number of individuals from baseline (a positive number) indicates an increase in their social network size.

    Measured: Baseline and 3 months post-intervention (Immediate Group) or 3 months post-baseline (Delayed Group)

  7. Change From Baseline in Valuation of Life

    This self-reported 13 question measure asks the participant how much they agree or disagree on a 5 point Likert scale when asked a statement about the meaning of life and personal goals. Score ranges from 0 to 65. Higher score means higher value of life.

    Change from baseline score is reported. An increase in the score from baseline (a positive number) indicates a higher value of life.

    Measured: Baseline and 3 months post-intervention (Immediate Group) or 3 months post-baseline (Delayed Group)

  8. Change From Baseline in Adapted From Attitudes Towards Computers Questionnaire (ATCQ): Computer Self-Efficacy

    A 5 question measure surveying self-reported self-efficacy of computer use on a 5 point Likert scale. Score ranges from 0 to 25.

    Change from baseline score is reported. An increase in the score from baseline (a positive number) indicates a higher self-efficacy.

    Measured: Baseline and 3 months post-intervention (Immediate Group) or 3 months post-baseline (Delayed Group)

  9. Change From Baseline in Adapted From Attitudes Towards Computers Questionnaire (ATCQ): Device Self-Efficacy

    A 5 question measure surveying self-reported device self-efficacy on a 5 point Likert scale. Score ranges from 0 to 25.

    Change from baseline score is reported. An increase in the score from baseline (a positive number) indicates a higher self-efficacy.

    Measured: Baseline and 3 months post-intervention (Immediate Group) or 3 months post-baseline (Delayed Group)

  10. Change From Baseline in Adapted From Attitudes Towards Computers Questionnaire (ATCQ): Listening Device Interest

    A 5 question measure surveying self-reported self-efficacy of listening device interest on a 5 point Likert scale. Score ranges from 0 to 25.

    Change from baseline score is reported. An increase in the score from baseline (a positive number) indicates a higher self-efficacy.

    Measured: Baseline and 3 months post-intervention (Immediate Group) or 3 months post-baseline (Delayed Group)

  11. Change From Baseline in Adapted From Listening Self-Efficacy Questionnaire (LSEQ): Total Score

    This 5 question survey measures listening self efficacy on a 0-10 scale in different situations such as being able to understand a conversation in a quiet room to a crowded restaurant. Participants answer with a higher number the more confident they are in the presented situation. Maximum possible score is 50.

    Change from baseline score is reported. An increase in the score from baseline (a positive number) indicates a higher self-efficacy.

    Measured: Baseline and 3 month post-intervention (immediate group) or 3 month post-baseline (delayed group)

  12. Change From Baseline in Adapted From Listening Self-Efficacy Questionnaire (LSEQ): Complex Listening

    This measure is the combined score of two questions where a participant self-reported their listening self efficacy on a 0-10 scale in complex listening situations. Participants answer with a higher number the more confident they are in the presented situation. Score ranges from 0 to 20.

    Change from baseline score is reported. An increase in the score from baseline (a positive number) indicates a higher self-efficacy.

    Measured: Baseline and 3 month post-intervention (immediate group) or 3 month post-baseline (delayed group)

  13. Change From Baseline in Adapted From Listening Self-Efficacy Questionnaire (LSEQ): Directed Listening

    This measure is the combined score of two questions where a participant self-reported their listening self efficacy on a 0-10 scale in complex listening situations. Participants answer with a higher number the more confident they are in the presented situation. Score ranges from 0 to 20.

    Change from baseline score is reported. An increase in the score from baseline (a positive number) indicates a higher self-efficacy.

    Measured: Baseline and 3 month post-intervention (immediate group) or 3 month post-baseline (delayed group)

  14. Change From Baseline in Adapted From Listening Self-Efficacy Questionnaire (LSEQ): Dialog in Quiet

    This measure is a participant's self-reported listening self efficacy on a 0-10 score scale in a dialog in quiet listening situation. Participants answer with a higher number the more confident they are in the presented situation. Maximum possible score is 10.

    Change from baseline score is reported. An increase in the score from baseline (a positive number) indicates a higher self-efficacy.

    Measured: Baseline and 3 month post-intervention (immediate group) or 3 month post-baseline (delayed group)

  15. Change From Baseline in Hearing Knowledge

    This 5 question measure asks participants about their hearing knowledge based on the information presented in the intervention. The score ranges from 0 to 5.

    Change from baseline score is reported. An increase in the score from baseline (a positive number) indicates more hearing knowledge.

    Measured: Baseline and 3 month post-intervention (immediate group) or 3 month post-baseline (delayed group)

  16. Change From Baseline in Hearing Handicap Inventory for the Elderly (HHIE-S)

    Measure was collected through a one-on-one interview with a trained data collector. Higher scores indicate increased hearing handicap.

    Scoring:

    0-8 suggests no hearing handicap 10-24 suggests mild-moderate hearing handicap 26-40 suggests significant hearing handicap.

    Change from baseline is reported. An increase in the score from baseline (a positive number) indicates a worsening in hearing handicap.

    Measured: Baseline and 12 months post-intervention

  17. Change From Baseline in Revised UCLA Loneliness Scale

    Measure was collected via a one-on-one interview conducted by a trained data collector.

    Score is the sum of 20-item self-reported measure. Scores range from 20 to 80.

    Score ranges:

    20-34 - Low degree of loneliness 35-49 - Moderate degree of loneliness 50-64 - Moderately high degree of loneliness 65-80 - High degree of loneliness.

    Change from baseline is reported. An increase in the score from baseline (a positive number) indicates a worsening in degree of loneliness.

    Measured: Baseline and 12 months post-intervention

  18. Change From Baseline in Self-reported Depression in Patient Health Questionnaire (PHQ-9)

    Measure collected via one-on-one interview conducted by trained data collectors.

    Total of 9 questions, scored from 0 to 3. The score from each question are summed to a total score, which can range from 0 to 27.

    Interpretation of Total Score Total Score Depression Severity 0 No depression 1-4 Minimal depression 5-9 Mild depression 10-14 Moderate depression 15-19 Moderately severe depression 20-27 Severe depression.

    Change from baseline is reported. An increase in the score from baseline (a positive number) indicates a worsening in depression severity.

    Measured: Baseline and 12 months post-intervention

  19. Change From Baseline in Short Form -12 (SF-12) Mental Component Score

    The 12-Item Short Form Survey (SF-12) was collected through a one-on-one interview with a trained data collector.

    The 12-Item Short Form Survey (SF-12) measures the construct of self-reported health-related quality of life. Here we report the mental component which relates to mental health functioning. Score ranges from 0-100 with higher scores indicating better mental health functioning.

    Change from baseline is reported. An increase in the score from baseline (a positive number) indicates a better health state.

    Measured: Baseline and 12 months post-intervention

  20. Change From Baseline in Short Form -12 (SF-12) Physical Component Score

    The 12-Item Short Form Survey (SF-12) was collected through a one-on-one interview with a trained data collector.

    The 12-Item Short Form Survey (SF-12) measures the construct of self-reported health-related quality of life. Here we report the physical component which relates to physical health functioning. Score ranges from 0-100 with higher scores indicating better physical health functioning.

    Change from baseline is reported. An increase in the score from baseline (a positive number) indicates a better health state.

    Measured: Baseline and 12 months post-intervention

  21. Change From Baseline in Cohen (Social Network Index) SNI: Network Diversity

    Change from baseline in total number of high contact roles the participant interacts with at least every 2 weeks (such as family, friends, work). Maximum of 12 roles included on the measure. An increase in the number of roles from baseline (a positive number) indicates a more diverse network.

    Measured: Baseline and 12 months post-intervention

  22. Change From Baseline in Cohen Social Network Index (SNI): Social Network Size

    Change from baseline in total number of individuals in high contact roles the participant interacts with at least every 2 weeks (such as family, friends, work). .An increase in the number of individuals from baseline (a positive number) indicates an increase in their social network size.

    Measured: Baseline and 12 months post-intervention

  23. Change From Baseline in Valuation of Life

    This self-reported 13 question measure asks the participant how much they agree or disagree on a 5 point Likert scale when asked a statement about the meaning of life and personal goals. Score ranges from 0 to 65. Higher score means higher value of life.

    Change from baseline score is reported. An increase in the score from baseline (a positive number) indicates a higher value of life.

    Measured: Baseline and 12 months post-intervention

  24. Change From Baseline in Adapted From Attitudes Towards Computers Questionnaire (ATCQ): Device Self-Efficacy

    A 5 question measure surveying self-reported device self-efficacy on a 5 point Likert scale. Score ranges from 0 to 25.

    Change from baseline score is reported. An increase in the score from baseline (a positive number) indicates a higher self-efficacy.

    Measured: Baseline and 12 months post-intervention

  25. Change From Baseline in Adapted From Attitudes Towards Computers Questionnaire (ATCQ): Computer Self-Efficacy

    A 5 question measure surveying self-reported self-efficacy of computer use on a 5 point Likert scale. Score ranges from 0 to 25.

    Change from baseline score is reported. An increase in the score from baseline (a positive number) indicates a higher self-efficacy.

    Measured: Baseline and 12 months post-intervention

  26. Change From Baseline in Adapted From Attitudes Towards Computers Questionnaire (ATCQ): Listening Device Interest

    A 5 question measure surveying self-reported self-efficacy of listening device interest on a 5 point Likert scale. Score ranges from 0 to 25.

    Change from baseline score is reported. An increase in the score from baseline (a positive number) indicates a higher self-efficacy.

    Measured: Baseline and 12 months post-intervention

  27. Change From Baseline in Adapted From Listening Self-Efficacy Questionnaire (LSEQ): Total Score

    This 5 question survey measures listening self efficacy on a 0-10 scale in different situations such as being able to understand a conversation in a quiet room to a crowded restaurant. Participants answer with a higher number the more confident they are in the presented situation. Maximum possible score is 50.

    Change from baseline score is reported. An increase in the score from baseline (a positive number) indicates a higher self-efficacy.

    Measured: Baseline and 12 months post-intervention

  28. Change From Baseline in Adapted From Listening Self-Efficacy Questionnaire (LSEQ): Complex Listening

    This measure is the combined score of two questions where a participant self-reported their listening self efficacy on a 0-10 scale in complex listening situations. Participants answer with a higher number the more confident they are in the presented situation. Score ranges from 0 to 20.

    Change from baseline score is reported. An increase in the score from baseline (a positive number) indicates a higher self-efficacy.

    Measured: Baseline and 12 months post-intervention

  29. Change From Baseline in Adapted From Listening Self-Efficacy Questionnaire (LSEQ): Directed Listening

    This measure is the combined score of two questions where a participant self-reported their listening self efficacy on a 0-10 scale in directed listening situations. Participants answer with a higher number the more confident they are in the presented situation. Score ranges from 0 to 20.

    Change from baseline score is reported. An increase in the score from baseline (a positive number) indicates a higher self-efficacy.

    Measured: Baseline and 12 months post-intervention

  30. Change From Baseline in Adapted From Listening Self-Efficacy Questionnaire (LSEQ): Dialog in Quiet

    This measure is a participant's self-reported listening self efficacy on a 0-10 scale in a directed listening situation. Participants answer with a higher number the more confident they are in the presented situation. Maximum possible score is 10.

    Change from baseline score is reported. An increase in the score from baseline (a positive number) indicates a higher self-efficacy.

    Measured: Baseline and 12 months post-intervention

  31. Change From Baseline in Hearing Knowledge

    This 5 question measure asks participants about their hearing knowledge based on the information presented in the intervention. Score ranges from 0 to 5.

    Change from baseline score is reported. An increase in the score from baseline (a positive number) indicates more hearing knowledge.

    Measured: Baseline and 12 months post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Feb 2018
  2. Study start18 Apr 2018
  3. Primary completion17 Jun 2020
  4. Study completion14 Jul 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
151 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03442296
Sponsor's protocol ID
IRB00144968
Other IDs
R33DC015062-03
Acronym
HEARS
Status last verified
Sep 2022
First submitted
6 Feb 2018
Last updated
4 Oct 2022
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Ventry IM, Weinstein BE. Identification of elderly people with hearing problems. ASHA. 1983 Jul;25(7):37-42. No abstract available.

    PubMed 6626295
  • Weinstein BE. Validity of a screening protocol for identifying elderly people with hearing problems. ASHA. 1986 May;28(5):41-5. No abstract available.

    PubMed 3718608
  • Tuley MR, Mulrow CD, Aguilar C, Velez R. A critical reevaluation of the Quantified Denver Scale of Communication Function. Ear Hear. 1990 Feb;11(1):56-61. doi: 10.1097/00003446-199002000-00011.

    PubMed 2307305
  • Russell D, Peplau LA, Cutrona CE. The revised UCLA Loneliness Scale: concurrent and discriminant validity evidence. J Pers Soc Psychol. 1980 Sep;39(3):472-80. doi: 10.1037//0022-3514.39.3.472.

    PubMed 7431205
  • Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care. 1988 Jul;26(7):724-35. doi: 10.1097/00005650-198807000-00007. No abstract available.

    PubMed 3393032
  • Nieman CL, Betz J, Garcia Morales EE, Suen JJ, Trumbo J, Marrone N, Han HR, Szanton SL, Lin FR. Effect of a Community Health Worker-Delivered Personal Sound Amplification Device on Self-Perceived Communication Function in Older Adults With Hearing Loss: A Randomized Clinical Trial. JAMA. 2022 Dec 20;328(23):2324-2333. doi: 10.1001/jama.2022.21820.

    PubMed 36538311
  • Marrone NL, Nieman CL, Coco L. Community-Based Participatory Research and Human-Centered Design Principles to Advance Hearing Health Equity. Ear Hear. 2022 Jul-Aug 01;43(Suppl 1):33S-44S. doi: 10.1097/AUD.0000000000001183. Epub 2020 Jun 13.

    PubMed 35724253

Questions about this trial

What is this clinical trial studying?

A study testing Baltimore HEARS in people with Age-related Hearing Impairment 1 and Personal Communication, run by Johns Hopkins University at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 14 Oct 2021). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change From Baseline in Hearing Handicap Inventory for the Elderly (HHIE-S) (time frame: Baseline and 3 months post-intervention (Immediate Group) or 3 months post-baseline (Delayed Group)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03442296, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Oct 2022; AzTrials last refreshed its copy on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in